Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Change in Accured Expenses (2013 - 2026)

Xencor (XNCR) posted quarterly Change in Accured Expenses of -$707000.0 for Q1 2026, up 77.58% year-over-year from -$398121.4 in Q1 2025, and down 110.18% quarter-over-quarter from $6.9 million in Q4 2025.

Analysis

Xencor (XNCR) Change in Accured Expenses (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Change in Accured Expenses for 14 consecutive years, with -$707000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Accured Expenses rose 77.58% year-over-year to -$707000.0; the TTM figure through Mar 2026 stood at $16.2 million (up 531.53% YoY), while the FY2025 annual figure was $13.8 million, up 417.37% from the prior year.
  • Change in Accured Expenses eased to -$707000.0 in Q1 2026 per XNCR's latest filing, from $6.9 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $6.9 million in Q4 2025 and bottomed at -$10.1 million in Q1 2024.
  • Historically, Change in Accured Expenses has averaged $756647.1 across 5 years, with a median of $2.9 million in 2022.
  • Annual changes were most pronounced in 2024 — Change in Accured Expenses tumbled 581.72% — and 2025, when it jumped 212.15%.
  • Xencor's Change in Accured Expenses stood at -$561000.0 in 2022, then tumbled by 61.85% to -$908000.0 in 2023, then sank by 581.72% to -$6.2 million in 2024, then surged by 212.15% to $6.9 million in 2025, then tumbled by 110.18% to -$707000.0 in 2026.
  • Business Quant data shows XNCR's Change in Accured Expenses at -$707000.0 in Q1 2026, $6.9 million in Q4 2025, and $4.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Xencor 2.02 Bn 1.65 Bn - 2.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.18 Mn
Mar 31, 2026 -707,000.00
Dec 31, 2025 6.94 Mn
Sep 30, 2025 4.22 Mn
Jun 30, 2025 5.79 Mn
Mar 31, 2025 -3.15 Mn
Dec 31, 2024 -6.19 Mn
Sep 30, 2024 5.85 Mn
Jun 30, 2024 6.07 Mn
Mar 31, 2024 -10.07 Mn
Dec 31, 2023 -908,000.00
Sep 30, 2023 6.03 Mn
Jun 30, 2023 3.30 Mn
Mar 31, 2023 -3.59 Mn
Dec 31, 2022 -561,000.00
Sep 30, 2022 2.94 Mn
Jun 30, 2022 3.74 Mn
Mar 31, 2022 -6.83 Mn
Dec 31, 2021 -2.67 Mn
Sep 30, 2021 4.78 Mn